Effects of Ocrevus in Relapsing Multiple Sclerosis (MOBILE-RMS)
Effects and Mechanisms of Ocrevus on Ambulatory Functions in People With Relapsing Multiple Sclerosis
Sponsor: Georgia State University
This PHASE4 trial investigates Relapsing Multiple Sclerosis and is currently ongoing. Georgia State University leads this study, which shows 15 recorded versions since 2021 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
15 versions recorded-
Feb 2026 — Present [monthly]
Active Not Recruiting PHASE4
-
Jan 2026 — Feb 2026 [monthly]
Active Not Recruiting PHASE4
-
May 2025 — Jan 2026 [monthly]
Active Not Recruiting PHASE4
-
Sep 2024 — May 2025 [monthly]
Active Not Recruiting PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting PHASE4
▶ Show 10 earlier versions
-
May 2024 — Jul 2024 [monthly]
Active Not Recruiting PHASE4
Status: Recruiting → Active Not Recruiting
-
Dec 2023 — May 2024 [monthly]
Recruiting PHASE4
-
Sep 2022 — Dec 2023 [monthly]
Recruiting PHASE4
-
Oct 2021 — Sep 2022 [monthly]
Recruiting PHASE4
-
Jun 2021 — Oct 2021 [monthly]
Recruiting PHASE4
Status: Not Yet Recruiting → Recruiting
-
Mar 2021 — Jun 2021 [monthly]
Not Yet Recruiting PHASE4
-
Jan 2021 — Mar 2021 [monthly]
Not Yet Recruiting PHASE4
-
Dec 2020 — Jan 2021 [monthly]
Not Yet Recruiting PHASE4
-
Aug 2020 — Dec 2020 [monthly]
Not Yet Recruiting PHASE4
-
Jun 2020 — Aug 2020 [monthly]
Not Yet Recruiting PHASE4
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Georgia State University
- Multiple Sclerosis Center of Atlanta
For direct contact, visit the study record on ClinicalTrials.gov .